Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

According to a report by the Barrons financial media, shares of the NYSE-listed health care product manufacturer, Johnson & Johnson, could surge almost 20% to the mid-$130s as a result of a faster earnings growth.

Johnson & Johnson shares closed higher for the first time in the past three trading sessions on Friday. The stock surged 1.14% ($1.27) to $112.26, after going up as high as $112.43 a share, or a level not seen since December 6th ($113.20). The daily performance has been the strongest since November 9th, when the stock rose 2.79%. In the week ended on December 11th J&J shares rose 0.27% compared to a week ago, while marking their first gain in the past four weeks. The stock has advanced 0.86% so far during the current month. November, on the other hand, marked the fourth consecutive monthly drop (-4.04%).

The report pointed out a sound development in Johnson & Johnsons consumer and medical devices businesses, while also adding that potentially lower corporate taxes, as envisioned by the Trump administration, might actually benefit the health care-specialized company.

In addition, another factor to support the companys stock was lower concern over competition for J&Js Remicade arthritis drug.

Johnson & Johnsons sales of medical devices worldwide went up 1.1% to reach $6.16 billion during the third quarter of 2016, while its sales of consumer products decreased 1.6% to $3.26 billion during the period.

Daily and Weekly Pivot Levels

With the help of the Camarilla calculation method, todays levels of importance for the Johnson & Johnson stock are presented as follows:

R1 – $112.37
R2 – $112.49
R3 (Range Resistance – Sell) – $112.60
R4 (Long Breakout) – $112.94
R5 (Breakout Target 1) – $113.33
R6 (Breakout Target 2) – $113.50

S1 – $112.15
S2 – $112.03
S3 (Range Support – Buy) – $111.92
S4 (Short Breakout) – $111.58
S5 (Breakout Target 1) – $111.19
S6 (Breakout Target 2) – $111.02

By using the traditional method of calculation, the weekly levels of importance for Johnson & Johnson (JNJ) are presented as follows:

Central Pivot Point – $111.59
R1 – $113.87
R2 – $115.47
R3 – $117.75
R4 – $120.02

S1 – $110.00
S2 – $107.71
S3 – $106.11
S4 – $104.50

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Crude oil trading outlook: futures steady after PBOC cuts rates, OPEC disagreements eyedCrude oil trading outlook: futures steady after PBOC cuts rates, OPEC disagreements eyed Both West Texas Intermediate and Brent crude were little changed after China surprisingly reduced its interest rates, before the long awaited OPEC meeting on Thursday this week. A strong dollar weighed on prices.January US crude fell 0.03% […]
  • Australian Dollar Steady as Policy and Jobs Data LoomAustralian Dollar Steady as Policy and Jobs Data Loom Key Moments First, the US Dollar remains under pressure after Trump escalated tensions over Greenland, unwinding recent hawkish USD positioning. Meanwhile, the Reserve Bank of Australia has adopted a more hawkish tone, with […]
  • Wheat Futures Ease After Rally as Supply Outlook ShiftsWheat Futures Ease After Rally as Supply Outlook Shifts Key Moments Wheat futures followed Thursday's broad rally with mild weakness across KC HRW, Chicago SRW, and MPLS spring contracts early Friday. Weekly U.S. wheat export sales showed 129,022 MT of old-crop bookings, led by […]
  • Forex Market: NZD/CAD daily forecastForex Market: NZD/CAD daily forecast During yesterday’s trading session NZD/CAD traded within the range of 0.9202-0.9300 and closed at 0.9224.At 8:33 GMT today NZD/CAD was losing 0.09% for the day to trade at 0.9230. The pair touched a daily low at 0.9204 at 7:45 […]
  • Forex Market: EUR/CHF daily trading forecastForex Market: EUR/CHF daily trading forecast Yesterday’s trade saw EUR/CHF within the range of 1.2067-1.2115. The pair closed at 1.2090, gaining 0.03% on a daily basis.At 6:18 GMT today EUR/CHF was down 0.01% for the day to trade at 1.2088. The pair touched a daily low at 1.2084 […]
  • Eli Lilly Slides as FDA Case Sparks GLP-1 Safety TalkEli Lilly Slides as FDA Case Sparks GLP-1 Safety Talk Key Moments Eli Lilly and Company (NYSE:LLY) declined 3% while Novo Nordisk (NYSE:NVO) gained 2% after an analyst highlighted an FDA liver failure case involving Eli Lilly’s oral GLP-1 drug Foundayo. The liver failure case, […]